The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes

WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity

(2017) Nathalie Ferrand et al.   Scientific Reports

Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity

(2017) Christopher Tacke et al.   Journal of Cell Communication and Signaling

Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity

(2016) Marlies Bekaert et al.   Obesity

WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling

(2015) Azusa Maeda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Insulin resistance and impaired adipogenesis

(2015) Birgit Gustafson et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

(2015) Thomas E. Akie et al.   Jove-Journal of Visualized Experiments

WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity

(2014) Veronica Murahovschi et al.   DIABETES

Role of Heme Oxygenase-1 in Postnatal Differentiation of Stem Cells: A Possible Cross-Talk with MicroRNAs

(2013) Magdalena Kozakowska et al.   ANTIOXIDANTS & REDOX SIGNALING

Restricted Adipogenesis in Hypertrophic Obesity

(2013) Birgit Gustafson et al.   DIABETES

Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells

(2013) C. Wiza et al.   DIABETOLOGIA

Characterization of the Wnt Inhibitors Secreted Frizzled-Related Proteins (SFRPs) in Human Adipose Tissue

(2013) Anna Ehrlund et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade

(2013) Luca Vanella et al.   Stem Cell Research & Therapy

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Cross-talk between Insulin and Wnt Signaling in Preadipocytes

(2012) Jane Palsgaard et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sex Steroid-Induced Changes in Circulating Monocyte Chemoattractant Protein-1 Levels May Contribute to Metabolic Dysfunction in Obese Men

(2012) Johannes B. Ruige et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The complex world of WNT receptor signalling

(2012) Christof Niehrs   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Secreted and Transmembrane Wnt Inhibitors and Activators

(2012) C.-M. Cruciat et al.   Cold Spring Harbor Perspectives in Biology

Functional annotation of the human fat cell secretome

(2012) Ingrid Dahlman et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

The Akt kinases: Isoform specificity in metabolism and cancer

(2011) Eva Gonzalez et al.   CELL CYCLE

CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer

(2011) G. Lorenzatti et al.   JOURNAL OF CELL SCIENCE

WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity

(2010) Mitsuaki Ono et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity

(2010) N. Ouchi et al.   SCIENCE

Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance

(2008) M. Li et al.   DIABETES